Literature DB >> 15351504

High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells.

Hsiao T Ni1, Shuxian Hu, Wen S Sheng, Judy M Olson, Maxim C-J Cheeran, Anissa S H Chan, James R Lokensgard, Phillip K Peterson.   

Abstract

Neural precursor cells (NPCs) are self-renewing, multipotent progenitors that give rise to neurons, astrocytes and oligodendrocytes in the central nervous system (CNS). Fetal NPCs have attracted attention for their potential use in studying normal CNS development. Several studies of rodent neural progenitors have suggested that chemokines and their receptors are involved in directing NPC migration during CNS development. In this study, we established a consistent system to culture human NPCs and examined the expression of chemokine receptors on these cells. NPCs were found to express the markers nestin and CD133 and to differentiate into neurons, astrocytes and oligodendrocytes at the clonal level. Flow cytometry and RNase protection assay (RPA) indicated that NPCs express high levels of CXCR4 and low levels of several other chemokine receptors. When examined using a chemotaxis assay, NPCs were able to respond to CXCL12/SDF-1alpha, a ligand of CXCR4. Treatment with anti-CXCR4 antibody or HIV-1 gp120 abolished the migratory response of NPCs towards CXCL12/SDF-1alpha. These findings suggest that CXCR4 may play a significant role in directing NPC migration during CNS development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351504     DOI: 10.1016/j.devbrainres.2004.06.015

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  29 in total

1.  The HIV-1 coat protein gp120 regulates CXCR4-mediated signaling in neural progenitor cells.

Authors:  Phuong B Tran; Dongjun Ren; Richard J Miller
Journal:  J Neuroimmunol       Date:  2004-12-28       Impact factor: 3.478

Review 2.  Mechanistic insights into the regulation of the spermatogonial stem cell niche.

Authors:  Rex A Hess; Paul S Cooke; Marie-Claude Hofmann; Kenneth M Murphy
Journal:  Cell Cycle       Date:  2006-06-01       Impact factor: 4.534

Review 3.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 4.  Current perspectives on the link between neuroinflammation and neurogenesis.

Authors:  Brian Wang; Kunlin Jin
Journal:  Metab Brain Dis       Date:  2014-03-13       Impact factor: 3.584

5.  TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.

Authors:  V Egea; L von Baumgarten; C Schichor; B Berninger; T Popp; P Neth; R Goldbrunner; Y Kienast; F Winkler; M Jochum; C Ries
Journal:  Cell Death Differ       Date:  2010-12-03       Impact factor: 15.828

Review 6.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

Authors:  Mark L Hanke; Tammy Kielian
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

7.  The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype.

Authors:  Sara Szuchet; Joseph A Nielsen; Gabor Lovas; Miriam S Domowicz; Javier M de Velasco; Dragan Maric; Lynn D Hudson
Journal:  Eur J Neurosci       Date:  2011-12-02       Impact factor: 3.386

Review 8.  Immunological control of adult neural stem cells.

Authors:  Oscar Gonzalez-Perez; Alfredo Quiñones-Hinojosa; Jose Manuel Garcia-Verdugo
Journal:  J Stem Cells       Date:  2010

9.  Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain.

Authors:  Phuong B Tran; Ghazal Banisadr; Dongjun Ren; Anjen Chenn; Richard J Miller
Journal:  J Comp Neurol       Date:  2007-02-20       Impact factor: 3.215

Review 10.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.